TRDA

UNKNOWN

Entrada Therapeutics, Inc.

CIK: 0001689375

Strong Sell (70% confidence)

Last activity: 3 days ago

Financial Metrics

As of Dec 31, 2025 (10-K)

Total Cash $90.39M

Insider	Buys	Sells	Net Value	Holdings
WENTWORTH KORY JAMES Chief Financial Officer	0	4	-$345K	119,010 shares $1.54M
Dowden Nathan J President & COO	0	2	-$196K	198,588 shares $2.59M

SELL WENTWORTH KORY JAMES (Chief Financial Officer)

2,500 shares @ $12.95

$32K

Apr 1, 2026

Conviction: | View SEC Filing →

SELL Dowden Nathan J (President & COO)

11,894 shares @ $13.05

$155K

Mar 10, 2026

Conviction: | View SEC Filing →

SELL WENTWORTH KORY JAMES (Chief Financial Officer)

11,388 shares @ $13.02

$148K

Mar 10, 2026

Conviction: | View SEC Filing →

SELL WENTWORTH KORY JAMES (Chief Financial Officer)

5,089 shares @ $13.00

$66K

Mar 9, 2026

Conviction: | View SEC Filing →

SELL Dowden Nathan J (President & COO)

3,116 shares @ $13.02

$41K

Mar 9, 2026

Conviction: | View SEC Filing →

SELL WENTWORTH KORY JAMES (Chief Financial Officer)

7,988 shares @ $12.25

$98K

Mar 4, 2026

Conviction: | View SEC Filing →

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.